Society for Cardiovascular Angiography and Interventions
Society for Cardiovascular Angiography and Interventions
April 25, 2018
1 min read

SCAI launches new toolkit for PAD diagnosis, treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

SAN DIEGO — The Society for Cardiovascular Angiography and Interventions announced at its annual meeting the launch of the SCAI PAD Diagnosis and Treatment Resource Center, an ongoing, patient-centered quality improvement initiative focused on raising awareness of peripheral artery disease in the cardiology and internal medicine communities.

The new toolkit provides information on the underlying risks of PAD, which is estimated to impact more than 10 million patients in the United States, but is plagued by underdiagnosis a lack of screening and undertreatment.

PAD has been targeted as one of SCAI’s key areas for quality improvement, according to a press release issued during the meeting.

The new resource center features a collection of modules to improvement PAD management and outcomes:

  • PAD 101, with focus on the scope, prevalence, anatomy, risk factors, and classifications/clinical presentations;
  • PAD Diagnosis, with focus on appropriate screening and noninvasive testing;
  • PAD Medical Therapy, with focus on appropriate counseling, lifestyle changes, exercise and medical therapy, and outcomes;
  • PAD Invasive Therapy, with focus on when to refer for invasive revascularization and updates on select trial data on bare-metal stents, drug-eluting stents, drug-coated balloons and SCAI’s device selection clinical guidelines documents; and
  • PAD Care Coordination, with focus on long-term follow-up, coordination within a multidisciplinary team, quality of life and more.

In addition to the five-part modular series, the multiyear program will also feature a webcast series of 30-minute webcasts based upon the PAD Diagnosis and Treatment Resource Center topics.

PAD “is nearly as prevalent as CAD, yet still underdiagnosed. Early identification of PAD is key to proper counseling, risk factor modification and management to prevent future adverse clinical outcomes. The goal here is to provide PAD education, with incorporation of new clinical data in various formats, to inform and engage referring physicians, advanced practice providers and fellows-in-training,” Rajesh V. Swaminathan, MD, FSCAI, from Duke University Hospital, said in the release.


SCAI PAD Diagnosis and Treatment Resource Center.

Disclosure: The SCAI PAD Diagnosis and Treatment Resource Center is supported by Janssen.